MedTrace Logo

EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients

NCT00361426 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-07-19

No results posted yet for this study

Summary

Continuous measurement of breathing patterns, heart rate, restlessness and cough in sleep using EarlySense ES 16 device. Predicting worsening in COPD patients' condition using the above parameters.

Conditions

  • COPD Patients

Interventions

DEVICE

Earlysense vital sign monitor

The system is a contactless system that measures heart and respiratory rates and other parameters via a contactless sensor that is placed under the patient mattress

Sponsors & Collaborators

  • The Chaim Sheba Medical Center

    collaborator OTHER

  • EarlySense Ltd.

    lead INDUSTRY

Principal Investigators

  • Martine Szyper-Kravitz, M.D. · Haim Sheba Medical Center, Israel

Eligibility

Min Age
18 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00361426 on ClinicalTrials.gov